Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes

The optimization of adoptive transfer approaches of anti-tumor T cells requires both the functional improvement of the injected T cells and the modulation of the tumor microenvironment, favoring the recruitment of these T cells and their activation. We have recently shown the therapeutic benefit of...

Descripción completa

Detalles Bibliográficos
Autores principales: Marotte, L, Capitao, M, Deleine, C, Beauvais, T, Cadiou, G, Perrin, J., Chérel, M, Scotet, E, Guilloux, Y, Bruchertseifer, F, Morgenstern, A, Jarry, A, Gaschet, J., Labarriere, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237992/
https://www.ncbi.nlm.nih.gov/pubmed/34239774
http://dx.doi.org/10.1080/2162402X.2021.1940676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237992/
https://www.ncbi.nlm.nih.gov/pubmed/34239774
http://dx.doi.org/10.1080/2162402X.2021.1940676

Ejemplares similares